A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2006
11/02/2006	EP0973534B1 Plant extracts having appetite suppressant activity
11/02/2006	EP0950416B1 Use of TCF-II for the treatment of cancer related body weight loss, anaemia and TNF elevation
11/02/2006	EP0873361B1 Crystals of the ligand-binding domain of the thyroid hormone receptor complexed to a ligand
11/02/2006	CA2650556A1 Insulins combinations
11/02/2006	CA2606083A1 Method for evaluating compound using barlp and substance for regulating eating and body weight
11/02/2006	CA2605748A1 Novel specific caspase-10 inhibitors
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605381A1 Crystal polymorphism of 4'-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3',5'-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006	CA2605365A1 Remedy for xanthoma
11/02/2006	CA2605331A1 Calcium bis[(2s)-3-[3-[(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy]phenyl]-2-isopropoxypropionate] and intermediate thereof
11/02/2006	CA2605302A1 Combined pharmaceutical preparation for treatment of type 2 diabetes
11/02/2006	CA2603237A1 Novel nutraceutical compositions
11/02/2006	CA2599419A1 Dipeptidyl peptidase-iv inhibitors
11/01/2006	CN1856326A Combinations of a VEGF receptor inhibitor with other therapeutic agents
11/01/2006	CN1856303A Compositions for the treatment and prevention of diabetes mellitus
11/01/2006	CN1856301A Curable beta-amino acid
11/01/2006	CN1854305A Production of brain-tonifying nutrient oyster peptide
11/01/2006	CN1854300A Recombinant plasmid containing PON gene and its use
11/01/2006	CN1854151A Dopamine transfer protein peptide inhibitor and its use
11/01/2006	CN1853729A Preparation of polynuclear iron hydroxide-sugar composite
11/01/2006	CN1853722A Methods for preventing antipsychotic-induced weight gain
11/01/2006	CN1853716A Nutritive supplementary composition
11/01/2006	CN1853705A Medicine for treating cardiovascular disease
11/01/2006	CN1853704A Health-care food for lowering blood sugar and preparation thereof
11/01/2006	CN1853702A Chinese medicinal preparation for lowering blood sugar, blood fat and blood pressure, improving blood flow and immune and its making method
11/01/2006	CN1853692A Chinese medicinal composition for treating diabetes mellitus II
11/01/2006	CN1853676A Chinese Magnoliavine Fruit alcohol extract drip balls and preparation thereof
11/01/2006	CN1853666A Pharmaceutical, nutraceutical, dietetic and nutritional compositions based on vegetable fibres
11/01/2006	CN1853660A Erigeron breviscapus preparation and making method thereof
11/01/2006	CN1853654A Oral preparation containing pearl and vitamine
11/01/2006	CN1853653A Composition containing pearl and vitamine and its use
11/01/2006	CN1853650A Calcium-supplementing agent
11/01/2006	CN1853647A Use III of sealwort polysaccharide
11/01/2006	CN1853646A Compound three-vitamines B injection and preparation thereof
11/01/2006	CN1853637A Use of pentacyclic triterpene compound as glycogen phosphorylase inhibitor
11/01/2006	CN1853622A Use of setooquen
11/01/2006	CN1853618A Use of bromphenol compound in protein-tyrosine phosphonatease inhibitor
11/01/2006	CN1853617A Medicine based on anti-hyperglycaemic microcapsules with prolonged release
11/01/2006	CN1853507A Non-effect components for beverage or solid oral agent or food additive with weight-losing function
11/01/2006	CN1282641C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
11/01/2006	CN1282636C Vitamin D analogues
11/01/2006	CN1282484C Lipid reducing and regulating agent
11/01/2006	CN1282474C Medicine for treating hyper lipidemia and its preparing method
11/01/2006	CN1282473C Wild chrysanthemum granules and preparation method
11/01/2006	CN1282457C Composite for treating hyperlipidemia
11/01/2006	CN1282456C Paroxetine control-released composite
11/01/2006	CN1282419C 油组合物 Oil composition
10/2006
10/31/2006	US7129381 Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/31/2006	US7129378 Method of preparing amine stereoisomers
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129352 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129255 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/31/2006	US7129253 Compounds
10/31/2006	US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
10/31/2006	US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129239 Dietetics; cardiovascular disorders; strokes; antidiabetic agents, sleep disorders, osteoporosis
10/31/2006	US7129237 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006	US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group
10/31/2006	US7128914 Product containing an extract of red algae of the genus Porphyra and methods for protecting cells
10/31/2006	CA2427289C Fat composition and hexacosanoic acid depressant for oral or enteral administration
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2333405C Spill resistant pharmaceutical compositions
10/31/2006	CA2214670C 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives
10/31/2006	CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
10/26/2006	WO2006112737A1 Vesiculins
10/26/2006	WO2006112549A1 Fused heterocyclic compound
10/26/2006	WO2006112366A1 Lipopexia inhibitor and food or beverage
10/26/2006	WO2006112331A1 Novel condensed pyrrole derivative
10/26/2006	WO2006111833A1 Functional herbal cigarette in controlling body weight and composition
10/26/2006	WO2006111776A2 Pharmaceutical composition comprising serum obtained from a naive mammal
10/26/2006	WO2006111591A1 Method of preparing lycopene-enriched formulations that are free of organic solvents, formulations thus obtained, compositions comprising said formulations and use of same
10/26/2006	WO2006111424A1 Methods for identifying modulators of cb1 and cb2 cannabinoid receptors and their use in wound healing
10/26/2006	WO2006111321A1 Azole derivatives in the form of lipase and phospholipase inhibitors
10/26/2006	WO2006111261A1 Substituted 2-amin0alkylthi0-benzimidaz0les and use thereof for reducing blood sugar levels
10/26/2006	WO2006111103A1 Functions and uses of gpr39 gene in mammalian central nervous system
10/26/2006	WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006	WO2006085113A3 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists
10/26/2006	WO2006045710A3 Insulin receptor binding peptides with non-insulin gene activation profiles and uses thereof
10/26/2006	WO2005102301A3 Hydroxymethylbutyrate compositions and uses thereof
10/26/2006	WO2005079840A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
10/26/2006	US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006	US20060241299 Process for making spirolactone compounds
10/26/2006	US20060241177 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
10/26/2006	US20060241169 Crystalline forms of [R-(R.R)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
10/26/2006	US20060241157 Heterocyclic ppar modulators
10/26/2006	US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis
10/26/2006	US20060241138 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
10/26/2006	US20060241131 Pyrrolo[2,3-d]pyrimidine compounds
10/26/2006	US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006	US20060241123 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
10/26/2006	US20060241120 Cannabinoid Receptor Ligands and Uses Thereof
10/26/2006	US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
10/26/2006	US20060241113 Polyarylcarboxamides useful as lipid lowering agents

1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 1298